Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Ansell

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|February 7, 2016
How to select the frontline treatment for a patient with peripheral T-cell lymphomaStephen Ansell
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Novel agents in the therapy of Hodgkin lymphomaStephen Ansell
Clinical Lymphoma & Myeloma|October 10, 2006
Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignanciesLatha Shivakumar, Stephen Ansell
Leukemia Research|June 6, 2008
The use of cell lines for the study of Waldenström's macroglobulinemiaMorie Gertz, Stephen Ansell
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin LymphomaJose Caetano Villasboas, Stephen Ansell
Leukemia & Lymphoma|November 1, 2016
Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphomaJ C Villasboas, Stephen Ansell
Expert Review of Clinical Immunology|January 29, 2016
Checkpoint Inhibitors for the Treatment of Hodgkin LymphomaNabila Bennani-Baiti, Gita Thanarajasingam, Stephen Ansell
Expert Review of Hematology|November 20, 2015
Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and managementNabila Bennani-Baiti, Stephen Ansell, Andrew L Feldman
British Journal of Haematology|May 9, 2013
Waldenström macroglobulinaemia: the key questionsAnita D'Souza, Stephen Ansell, Craig Reeder, et al.
Kidney Medicine|February 13, 2025
Intracapillary Monoclonal IgM Deposition Concomitant With Cold Agglutinin DiseaseSilvia M Titan, Sandra Herrmann, Nelson Leung, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|February 7, 2016
How to select the frontline treatment for a patient with peripheral T-cell lymphomaStephen Ansell
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Novel agents in the therapy of Hodgkin lymphomaStephen Ansell
Clinical Lymphoma & Myeloma|October 10, 2006
Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignanciesLatha Shivakumar, Stephen Ansell
Leukemia Research|June 6, 2008
The use of cell lines for the study of Waldenström's macroglobulinemiaMorie Gertz, Stephen Ansell
Cancer Journal (Sudbury, Mass.)|February 4, 2016
Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin LymphomaJose Caetano Villasboas, Stephen Ansell
Leukemia & Lymphoma|November 1, 2016
Glancing at the complex biology of T-cells through the microenvironment of Hodgkin lymphomaJ C Villasboas, Stephen Ansell
Expert Review of Clinical Immunology|January 29, 2016
Checkpoint Inhibitors for the Treatment of Hodgkin LymphomaNabila Bennani-Baiti, Gita Thanarajasingam, Stephen Ansell
Expert Review of Hematology|November 20, 2015
Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and managementNabila Bennani-Baiti, Stephen Ansell, Andrew L Feldman
British Journal of Haematology|May 9, 2013
Waldenström macroglobulinaemia: the key questionsAnita D'Souza, Stephen Ansell, Craig Reeder, et al.
Kidney Medicine|February 13, 2025
Intracapillary Monoclonal IgM Deposition Concomitant With Cold Agglutinin DiseaseSilvia M Titan, Sandra Herrmann, Nelson Leung, et al.
Pageof 4